Autoimmune Hepatitis Clinical Trial
Official title:
Clinical Characteristics and Outcomes of Autoimmune Hepatitis: a Retro-prospective Multicenter Cohort in China
The goal of this observational study is to describe the clinical features and long-term prognosis in patients diagnosed with autoimmune hepatitis (AIH) in China and assess the effectiveness and safety of AIH treatment options in a real-world setting.
Autoimmune hepatitis (AIH) is a chronic autoimmune liver disease that causes liver inflammation and necrosis, ultimately leading to cirrhosis and liver failure. Although relatively rare, the prevalence of AIH in China has been increasing in recent years, highlighting its significance as a public health issue. However, due to the wide variability in the clinical presentation and outcomes of AIH, diagnosing and managing the disease can be challenging. Moreover, our understanding of the epidemiology, clinical features, diagnosis, and treatment of AIH in China is still limited. To address this gap in knowledge, the investigators are conducting the Chinese AIH Cohort study, which collects data from approximately 20 sites across China on treatment progress and success in clinical routine. The study aims to evaluate the effectiveness and safety/tolerability of different AIH treatment options, including standard therapy, and second and third-line treatment options. The investigators also record the long-term prognosis of patients with AIH, tracking whether they achieve remission, require liver transplantation, or experience mortality. Risk factors associated with long-term prognosis and survival will be analyzed to provide insights that can improve the diagnosis, treatment, and management of AIH in this population. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06020976 -
Pattern of Autoimmune Hepatitis in Children In Sohag University Hospital
|
||
| Recruiting |
NCT05476900 -
A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis.
|
Phase 2 | |
| Recruiting |
NCT05635266 -
A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
|
||
| Recruiting |
NCT06250309 -
Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patients
|
N/A | |
| Recruiting |
NCT01661842 -
Umbilical Cord Mesenchymal Stem Cells for Patients With Autoimmune Hepatitis
|
Phase 1/Phase 2 | |
| Terminated |
NCT04339621 -
AIH Risk Stratification With Multiparametric MRI
|
||
| Not yet recruiting |
NCT04371718 -
Effect of JKB-122 on Prednisolone and Azathioprine Induced Remission in Autoimmune Hepatitis (AIH)
|
Phase 2 | |
| Completed |
NCT02239562 -
sPIF CLINICAL STUDY PROTOCOL IN AUTOIMMUNE HEPATITIS
|
Phase 1 | |
| Recruiting |
NCT05569759 -
A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)
|
Phase 2 | |
| Completed |
NCT02463331 -
Association of Chloroquine and Prednisone as an Alternative Treatment for Autoimmune Hepatitis
|
Phase 4 | |
| Not yet recruiting |
NCT06356506 -
A Study on Factors of Biochemical Response in Autoimmune Hepatitis
|
||
| Terminated |
NCT04203875 -
Abatacept for Treatment of Recurrent or de Novo Autoimmune Hepatitis
|
Phase 1 | |
| Recruiting |
NCT06078098 -
Development of a Autoimmune Hepatitis Patient's Database Linked to a Biological Sample Storage
|
||
| Completed |
NCT00838214 -
Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune Hepatitis
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05810480 -
PredIcting sterOid depeNdEnt livEr injuRy With Polyreactive Immunoglobulin G
|
||
| Recruiting |
NCT03743272 -
Repeatability and Reproducibility of Multiparametric MRI
|
||
| Completed |
NCT03979053 -
Quantitative Magnetic Resonance Imaging to Aid Clinical Decision Making in Autoimmune Hepatitis.
|
||
| Not yet recruiting |
NCT04902807 -
Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
|
||
| Recruiting |
NCT04933292 -
A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome
|
Phase 4 | |
| Completed |
NCT05532345 -
Discrimination of DILI and AIH by Artificial Intelligence
|